Cargando…

Clinical profile in KMT2A-SEPT6-positive acute myeloid leukemia: Does it often co-occur with NRAS mutations?

BACKGROUND: The KMT2A-SEPT6 fusion gene is a relatively rare genetic event in leukemia. Its clinical characteristics and prognosis, especially the profile of co-occurring gene mutations remain unclear. METHODS: We retrospectively analyzed the characteristics of four cases carrying KMT2A-SEPT6 in our...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Fang, Yang, Ying, Fu, Shuang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532577/ https://www.ncbi.nlm.nih.gov/pubmed/36213638 http://dx.doi.org/10.3389/fmed.2022.890959

Ejemplares similares

Acute myeloid leukemia with KMT2A-SEPT5 translocation: A case report and review of the literature
por: Elzamly, Shaimaa, et al.
Publicado: (2018)

Mutational spectrum and prognosis in NRAS-mutated acute myeloid leukemia
por: Wang, Shujuan, et al.
Publicado: (2020)

A case of KMT2A–SEPT9 fusion–associated acute megakaryoblastic leukemia
por: Forlenza, Christopher J., et al.
Publicado: (2018)

Oncogenic NRAS Primes Primary Acute Myeloid Leukemia Cells for Differentiation
por: Brendel, Cornelia, et al.
Publicado: (2015)

Durable Disease Control with MEK Inhibition in a Patient with NRAS-mutated Atypical Chronic Myeloid Leukemia
por: Khanna, Vishesh, et al.
Publicado: (2015)

821. Portable Medical Equipment Disinfection: How often does it occur?
por: Jinadatha, Chetan, et al.
Publicado: (2020)

Predictors of outcomes in adults with acute myeloid leukemia and KMT2A rearrangements
por: Issa, Ghayas C., et al.
Publicado: (2021)

PB1799: KMT2A-REARRANGED PEDIATRIC ACUTE MYELOID LEUKEMIA
por: Zerkalenkova, E., et al.
Publicado: (2022)

Mutational landscape and clinical outcome of pediatric acute myeloid leukemia with 11q23/ KMT2A rearrangements
por: Yuen, Ka‐Yuk, et al.
Publicado: (2022)

RAB27B controls palmitoylation-dependent NRAS trafficking and signaling in myeloid leukemia
por: Ren, Jian-Gang, et al.
Publicado: (2023)

Rapid Adaptation Often Occurs through Mutations to the Most Highly Conserved Positions of the RNA Polymerase Core Enzyme
por: Cohen, Yasmin, et al.
Publicado: (2022)

Prognostic Significance of NRAS Gene Mutations in Children with Acute Myelogenous Leukemia
por: Aly, Rabab M., et al.
Publicado: (2011)

Effects of NRAS Mutations on Leukemogenesis and Targeting of Children With Acute Lymphoblastic Leukemia
por: Qian, Jiabi, et al.
Publicado: (2022)

The Partial Duplication of the 5′ Segment of KMT2A Revealed KMT2A-MLLT10 Rearrangement in a Boy with Acute Myeloid Leukemia
por: Fukushima, Hiroko, et al.
Publicado: (2017)

Both SEPT2 and MLL are down-regulated in MLL-SEPT2 therapy-related myeloid neoplasia
por: Cerveira, Nuno, et al.
Publicado: (2009)

Impact of KMT2A Rearrangement and CSPG4 Expression in Pediatric Acute Myeloid Leukemia
por: Hoffmeister, Lina Marie, et al.
Publicado: (2021)

KMT2D Deficiency Promotes Myeloid Leukemias which Is Vulnerable to Ribosome Biogenesis Inhibition
por: Xu, Jing, et al.
Publicado: (2023)

KRAS/NRAS/BRAF Mutation Rate in Saudi Academic Hospital Patients With Colorectal Cancer
por: Saharti, Samah
Publicado: (2022)

MLL2/KMT2D and MLL3/KMT2C expression correlates with disease progression and response to imatinib mesylate in chronic myeloid leukemia
por: Rabello, Doralina do Amaral, et al.
Publicado: (2018)

Mutational profile of ZBTB16‐RARA‐positive acute myeloid leukemia
por: Fabiani, Emiliano, et al.
Publicado: (2021)

Pediatric M5 acute myeloid leukemia with MLL-SEPT6 fusion and a favorable outcome
por: Chebly, Alain, et al.
Publicado: (2021)

Treatment of severe Kaposiform Lymphangiomatosis positive for NRAS mutation by MEK-inhibition
por: Chowers, Guy, et al.
Publicado: (2022)

Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemia
por: Wang, Feng, et al.
Publicado: (2021)

Novel Compounds Synergize With Venetoclax to Target KMT2A-Rearranged Pediatric Acute Myeloid Leukemia
por: Tregnago, Claudia, et al.
Publicado: (2022)

Allelic complexity of KMT2A partial tandem duplications in acute myeloid leukemia and myelodysplastic syndromes
por: Tsai, Harrison K., et al.
Publicado: (2022)

P435: NOVEL COMPOUNDS TO TARGET KMT2A-REARRANGED PEDIATRIC ACUTE MYELOID LEUKEMIA
por: Tregnago, Claudia, et al.
Publicado: (2023)

KMT2C mutation is a diagnostic molecular marker for primary thyroid osteosarcoma: A case report and literature review
por: Wang, Xinpei, et al.
Publicado: (2022)

P527: DISTINCTIVE CLONAL EVOLUTION PATTERN AND PROGNOSTIC SIGNIFICANCE OF THE CLONALITY OF KRAS MUTATIONS IN KMT2A-REARRANGED ACUTE MYELOID LEUKEMIA
por: Matsuo, Hidemasa, et al.
Publicado: (2023)

An Ocular Emergency Often Ignored
por: Cheemalapati, Shashank, et al.
Publicado: (2023)

Clinical Outcomes and Co-Occurring Mutations in Patients with RUNX1-Mutated Acute Myeloid Leukemia
por: Khan, Maliha, et al.
Publicado: (2017)

Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma: Occurence and prognostic significance
por: Módos, Orsolya, et al.
Publicado: (2016)

Transforming activities of the NUP98-KMT2A fusion gene associated with myelodysplasia and acute myeloid leukemia
por: Fisher, James N., et al.
Publicado: (2020)

Integration of Transcriptomic Features to Improve Prognosis Prediction of Pediatric Acute Myeloid Leukemia With KMT2A Rearrangement
por: Li, Jun, et al.
Publicado: (2023)

The KMT2A recombinome of acute leukemias in 2023
por: Meyer, C., et al.
Publicado: (2023)

Why Do Mania and Suicide Occur Most Often in the Spring?
por: Cho, Chul-Hyun, et al.
Publicado: (2018)

Immunotherapy- (Blinatumomab-) Related Lineage Switch of KMT2A/AFF1 Rearranged B-Lymphoblastic Leukemia into Acute Myeloid Leukemia/Myeloid Sarcoma and Subsequently into B/Myeloid Mixed Phenotype Acute Leukemia
por: He, Rui R., et al.
Publicado: (2019)

MEK1 is required for the development of NRAS-driven leukemia
por: Nowacka, Joanna D., et al.
Publicado: (2016)

Mutational Profiling of Malignant Mesothelioma Revealed Potential Therapeutic Targets in EGFR and NRAS
por: Kim, Jeong Eun, et al.
Publicado: (2018)

KRAS and NRAS mutational gene profile of metastatic colorectal cancer patients in Jordan
por: Awidi, Muhammad, et al.
Publicado: (2019)

Isolated Intracranial Myeloid Sarcoma Occurring as Relapse in Acute Myeloid Leukemia
por: Narayanan, Geetha, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_am9cb2ft8dloff3lkb0ua3od0b